ArticleHealth science reports2025
Recurrent Intradialytic Hypotension, Associated Risk Factors, and Outcomes in Northern Tanzania: A Retrospective Cohort Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Knowledge and Practice of Nurses on Prevention and Management of Intradialytic Hypotension at Kiruddu and Mulago National Referral Hospitals.International journal of nephrology and renovascular disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Intradialytic hypotension (IDH) is a common phenomenon during hemodialysis (HD), with profound complications and all-cause mortality. Data on IHD is scarce in Sub-Saharan Africa. The study aimed to evaluate the incidence, risk factors, and outcome associated with recurrent IDH among patients on maintenance HD. Methods: This was a retrospective cohort study conducted at the Kilimanjaro Christian Medical Centre HD unit between August 1, 2021 and July 31, 2022. In the study, 39 met the inclusion criteria, and a total of 4706 HD sessions were analyzed. The predictor was the occurrence of recurrent IDH. The outcomes were mortality from IDH, hospital admission due to IDH, and termination of the respective HD session. Descriptive statistics for categorical and continuous variables. A Results: The incidence of IDH was 4.35%; 46.3% of these IDH episodes were recurrent. Risk of IDH was higher in patients with pre-dialytic serum inorganic phosphate levels > 1.8 mmol/L (RR: 2.33, 95% CI: 1.02-5.35, Conclusion: Recurrent IDH is more common in males, among patients with hyperphosphatemia, and shows seasonal variations. Systolic blood pressure of < 140 mmHg confers a protective effect against recurrent IDH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.